LYEL - Lyell Immunopharma Inc
25.5
3.040 11.922%
Share volume: 231,146
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$22.46
3.04
0.14%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-06-2024 | 08-07-2024 | 11-07-2024 | 03-11-2025 | 05-13-2025 | 11-12-2025 | |
| Cash flow financing | 27.000 K | 862.000 K | 0.000 | 437.000 K | 1.000 K | 50.000 M | |
| Other financing cash flows | 27.000 K | 52.000 K | 0.000 | -1.000 K | 1.000 K | 0.000 | |
| Cash flow | -19.995 M | 7.775 M | 0.000 | 6.700 M | 14.729 M | 24.772 M | |
| Net income | -60.667 M | -45.809 M | -44.583 M | -191.935 M | -52.195 M | -38.846 M | |
| Depreciation | 5.024 M | 4.901 M | 4.680 M | 5.026 M | 3.441 M | 2.566 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 21.994 M | 45.007 M | 1.918 M | 53.505 M | 69.466 M | 3.349 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 30.000 K | 331.000 K | 59.000 K | 44.000 K | 246.000 K | 62.000 K | |
| Cash Change | -19.995 M | 7.775 M | -33.124 M | 6.700 M | 14.729 M | 24.772 M |